TrialAdvances in therapy2016

Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate.

Alberto Batticciotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.